UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003416
Receipt number R000004138
Scientific Title Cohort study of bevacizumab in combination with XELOX for metastatic colorectal cancer
Date of disclosure of the study information 2010/04/01
Last modified on 2014/04/08 20:01:16

No. Disposal Last modified on Item of update
1 Insert 2010/03/31 13:23:17
2 Update 2010/03/31 17:46:30 Key secondary outcomes
Key secondary outcomes
3 Update 2010/04/01 15:20:45 Last name of lead principal investigator
4 Update 2010/04/06 15:57:42 Public title
Acronym
5 Update 2010/04/06 15:58:33 Narrative objectives1
6 Update 2010/04/06 16:02:51 Trial characteristics_1
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
7 Update 2010/04/06 16:15:26 Study type
Basic design
Randomization
Blinding
Control
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key exclusion criteria
8 Update 2010/04/07 16:02:33 Organization
9 Update 2013/04/03 11:48:22 Recruitment status
Last follow-up date
Other related information
Other related information
10 Update 2013/11/06 16:38:26 Email
Email
Name of person sending information
Organization
Division name
Division name
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.
11 Update 2014/04/08 20:01:16 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results